---
title: "Apimeds Pharmaceuticals US (APUS.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/APUS.US/norm.md"
symbol: "APUS.US"
name: "Apimeds Pharmaceuticals US"
parent: "https://longbridge.com/en/quote/APUS.US.md"
datetime: "2026-03-04T06:49:03.219Z"
locales:
  - [en](https://longbridge.com/en/quote/APUS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/APUS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/APUS.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/APUS.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/APUS.US/norm.md)


# Apimeds Pharmaceuticals US (APUS.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1416 | -0.2567 | -0.0509 | -0.0394 | -0.0421 |
| ROE | -79.62% | -266.98% | 103.22% | 103.68% | 151.11% |
| Revenue | - | - | - | - | - |
| Net income | -1.78M | -2.66M | -402397.00 | -311633.00 | -332521.00 |
| Operating income | -1.84M | -2.66M | -364368.00 | -275613.00 | -299999.00 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 9.25M | 10.55M | 259904.00 | 13057.00 | 36907.00 |
| Leverage | 1.13 | 1.08 | -0.1476 | -0.0096 | -0.0353 |
| BVPS | 0.6489 | 0.7743 | -0.2227 | -0.1718 | -0.1324 |
| Turnover | - | - | - | - | - |
| Cash & STI | 6.99M | 8.74M | 250342.00 | 3455.00 | 26571.00 |
| Inv & Rec | - | - | - | - | - |
| LT assets | 34188.00 | 13137.00 | - | - | - |
| Net debt | -6.49M | -8.24M | 716978.00 | 669889.00 | 545421.00 |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -1.73M | -3.36M | -20313.00 | -99616.00 | -186755.00 |
| Investing CF | -22540.00 | -13369.00 | - | - | - |
| Financing CF | 0.0000 | 11.86M | 267200.00 | 76500.00 | 150000.00 |
| Free CF | -1.38M | -4.03M | 127578.00 | 14909.00 | -64263.00 |
| OCF coverage | -7658.23% | -3136.26% | - | - | - |
| Repaid & issued | 0.0000 | 200.00 | 267200.00 | 76500.00 | 150000.00 |
| CapEx | -22540.00 | -13369.00 | - | - | - |